戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 g treatment with 50 nM Compound 49b, a novel beta-adrenergic receptor agonist.
2         This is reversed by isoproterenol, a beta-adrenergic receptor agonist.
3 ve agonist, or isoprenaline, a non-selective beta-adrenergic receptor agonist.
4 also sensitizes the channel to activation by beta-adrenergic receptor agonists.
5 solated neonatal cardiac myocytes exposed to beta-adrenergic receptor agonists.
6  was threefold greater than that elicited by beta-adrenergic receptor agonists.
7 n the myocardium to exogenous and endogenous beta-adrenergic receptor agonists after burn injury may
8 haracteristics in response to treatment with beta-adrenergic receptor agonists and activators of aden
9 everal currently available therapies such as beta-adrenergic receptor agonists and antagonists, phosp
10                           Clinical trials of beta-adrenergic receptor agonists and cyclic nucleotide
11 all measured in response to isoproterenol, a beta-adrenergic receptor agonist, and carbachol, a choli
12                                              Beta-adrenergic receptor agonists are growth-promoting d
13           Administration of L-arginine and a beta-adrenergic receptor agonist (CL316, 243, respective
14                                              beta-Adrenergic receptor agonists had limited effects on
15 ion can inhibit the Cl- current activated by beta-adrenergic receptor agonists in guinea-pig ventricu
16               These studies demonstrate that beta-adrenergic receptor agonists in vitro can restore t
17                                          The beta-adrenergic receptor agonist isoprenaline (1 microM)
18 diated electrophysiological responses to the beta-adrenergic receptor agonist isoprenaline (Iso) in C
19 n/Hsp27 complex in response to the selective beta adrenergic receptor agonist isoproterenol, was subs
20  following intra-LS injections of either the beta-adrenergic receptor agonist isoproterenol (10 mug o
21              Angiotensin II (Ang II) and the beta-adrenergic receptor agonist isoproterenol (ISO) als
22                    Low concentrations of the beta-adrenergic receptor agonist isoproterenol (ISO) and
23                                          The beta-adrenergic receptor agonist isoproterenol (ISO) inc
24 ultures, we show that norepinephrine and the beta-adrenergic receptor agonist isoproterenol also inhi
25 ction were conducted using forskolin and the beta-adrenergic receptor agonist isoproterenol as agonis
26 er administration of either the nonselective beta-adrenergic receptor agonist isoproterenol or the be
27         Both angiotensin II (Ang II) and the beta-adrenergic receptor agonist isoproterenol selective
28 ions, ATP and UTP were not additive with the beta-adrenergic receptor agonist isoproterenol, but were
29 tion, either alone or in the presence of the beta-adrenergic receptor agonist isoproterenol, failed t
30  during periodic pacing in the presence of a beta-adrenergic receptor agonist isoproterenol, was sign
31 ibited enhanced inotropic sensitivity to the beta-adrenergic receptor agonist isoproterenol, with imp
32 l-4-phosphonophenylglycine (CPPG) and by the beta-adrenergic receptor agonist isoproterenol.
33 -) cells treated with 8-CPT-cAMP or with the beta-adrenergic receptor agonist isoproterenol.
34 tion of the Ca(2+) current stimulated by the beta-adrenergic receptor agonist isoproterenol.
35                    Chronic injections of the beta-adrenergic receptor agonist, isoproterenol, result
36 es were incubated with forskolin or with the beta-adrenergic receptor agonist, isoproterenol, to stim
37 lular signal-regulated kinases (ERKs) by the beta-adrenergic receptor agonist, isoproterenol.
38 following administration of isoproterenol, a beta-adrenergic receptor agonist known to induce cardiac
39 a condition associated with increases in the beta-adrenergic receptor agonist norepinephrine.
40  activity by forskolin, cAMP analogs, or the beta-adrenergic receptor agonists norepinephrine and iso
41                                              beta-adrenergic receptor agonists prevent the effects of
42 ce remained responsive to stimulation by the beta-adrenergic receptor agonist, (S)-isoproterenol.
43                           Interestingly, the beta-adrenergic receptor agonists, salbutamol, arterenol
44                                              Beta-adrenergic receptor agonists such as isoproterenol
45 change after treatment with isoproterenol, a beta-adrenergic receptor agonist that causes turnover of
46 ulation can be triggered by isoproterenol (a beta-adrenergic receptor agonist) treatment.
47 ary epithelial bilayer, when stimulated with beta adrenergic receptor agonists, vasointestinal peptid
48 reated some cells with Compound 49b, a novel beta-adrenergic receptor agonist we have reported previo
49 rly phase of LTP by pairing isoproterenol, a beta-adrenergic receptor agonist, with a weak train, sub

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。